DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA346554
Title:
Modulation of Molecular Markers by CLA
Descriptive Note:
Annual rept. 14 Sep 96-13 Sep 97
Corporate Author:
AMC CANCER RESEARCH CENTER DENVER CO
Report Date:
1997-10-01
Pagination or Media Count:
52.0
Abstract:
Conjugated linoleic acid CLA is a naturally occurring component of the food supply that inhibits mammary carcinogenesis. Data obtained on this project indicate 1 that the anticancer activity of CLA is unlikely to be explained based soley on its antioxidant activity 2 that CLA is unlikely to inhibit carcinogenesis by directly antagonizing linoleic acid metabolism 3 that CLA inhibits carcinogenesis irrespective of the presence or absence of the codon 61 mutation in the Ha-ras gene. Candidate genes that are over-expressed specifically in mammary carcinomas have been identified. The effects of CLA on the expression of these genes will be investigated to determined if they are involved in the inhibition of mammary carcinogenesis by CLA.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE